{"title": "Aiming to avoid Pfizer's Eucrisa failure, Arcutis wins FDA nod for Zoryve cream in psoriasis", "author": "Angus Liu", "url": "https://www.fiercepharma.com/marketing/aiming-avoid-pfizers-eucrisa-failure-arcutis-wins-fda-nod-zoryve-cream-psoriasis", "hostname": "fiercepharma.com", "description": "Pfizer once harbored blockbuster hopes for Eucrisa to be the next big topical treatment for inflammatory skin diseases. | Pfizer's Eucrisa never lived to become the next big topical treatment for inflammatory skin diseases. Now, young biotech Arcutis Biotherapeutics is bringing along a new therapy that goes after the same drug target but with a very different product profile.", "sitename": "FiercePharma", "date": "2022-07-29", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}